Swiss nonprofit BIO Association to launch BIO tokens for decentralized biotech network

  • Insights
  • September 30, 2024
  • 0 Comments

The BIO Association, a Swiss nonprofit, has unveiled plans to launch BIO tokens ahead of its decentralized biotech network, BIO Protocol, according to a Sept. 30 statement shared with CryptoSlate.

The association seeks to bridge the gap between biotechnology and crypto through its decentralized biotech network. This platform will serve as a launchpad for on-chain science communities.

In addition, it aims to democratize access to scientific research and funding. Central to this goal is creating BioDAOs—community-led organizations that develop and finance scientific intellectual property.

The BIO Association spun out from Molecule AG, a Swiss company specializing in tokenization infrastructure for DeSci organizations.

Currently, the BIO Network hosts eight scientific communities focused on longevity, women’s health, neurodegeneration, and synthetic biology. So, the initiative can potentially transform the biotech industry by leveraging blockchain technology and DeSci principles.

Notably, the platform has raised more than $5 million through an auction in August.

BIO token

The BIO Association has committed to a fair and transparent token launch designed to mirror major token releases. This approach highlights the community’s dedication to equal opportunity in the growing DeSci space.

Once the tokens are launched, users will be able to acquire BIO tokens using ETH or other DAO tokens within the BIO network.

The genesis phase will last 45 days or until the BIO token reaches a fully diluted valuation (FDV) of $100 million. After this period, the tokens will be non-transferable until a governance vote decides otherwise.

The token’s mainnet launch will occur on Ethereum, aligning with other leading DeSci projects.

BIO token holders will be able to vote on which new BioDAOs join the network. Additionally, they will gain whitelisted access to science-focused funding from top universities and researchers.

Meanwhile, early BIO Genesis token holders include ZeePrime Capital, Beaker DAO, Boost VC, 1kx, ID Theory, Compound, Cherry Crypto, L1D, Fifty Years, Northpond Ventures, KdT Ventures, Sora Ventures, and The LAO.

The post Swiss nonprofit BIO Association to launch BIO tokens for decentralized biotech network appeared first on CryptoSlate.

  • Related Posts

    Bitcoin’s on-chain flow is dominated by large value outputs

    In March, Bitcoin’s on-chain flow was heavily dominated by large value bands, with transactions sized at 10 BTC or more typically making up 85% to 90% of the total daily…

    Continue reading
    Solana co-founder apologizes for controversial ad targeting marginalized groups

    Solana Labs co-founder Anatoly Yakovenko said he is “ashamed” about downplaying the impact of a recent Solana Foundation advertisement, calling it “mean and punching down on a marginalized group.” Yakovenko…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Bitcoin’s on-chain flow is dominated by large value outputs

    Bitcoin’s on-chain flow is dominated by large value outputs

    Solana co-founder apologizes for controversial ad targeting marginalized groups

    Solana co-founder apologizes for controversial ad targeting marginalized groups

    BlackRock exec believes Bitcoin’s price does not reflect its strong institutional demand

    BlackRock exec believes Bitcoin’s price does not reflect its strong institutional demand

    Bitcoin reclaims $85k after Fed signals slowdown in quantitative tightening

    Bitcoin reclaims $85k after Fed signals slowdown in quantitative tightening

    Crypto.com reports record $1.5B revenue in 2024 to become the third largest exchange

    Crypto.com reports record $1.5B revenue in 2024 to become the third largest exchange

    Bitnomial set to launch CFTC-approved XRP futures on March 20, withdraws SEC lawsuit

    Bitnomial set to launch CFTC-approved XRP futures on March 20, withdraws SEC lawsuit